Abstract
Background
Glycosylated haemoglobin (HbA1c) correlates with the amount of hyperglycemia in diabetic patients. High HbA1c levels often predict clinically significant macular edema (CSME), which then needs to be treated with grid laser photocoagulation. The question asked in this study was whether there is a correlation between the effect grid laser photocoagulation in diffuse diabetic macular edema and HbA1c, using an optical coherence tomography (OCT) for the evaluation of the retinal thickness.
Methods
A prospective, non-comparative case series was performed to find a correlation between the effect of grid laser photocoagulation in diffuse diabetic macular edema and HbA1c. Thirty eyes with CSME of diabetic patients were included in the study. Complete ophthalmic examinations and OCT were performed at baseline, 1 month, 3, and 6 months after grid laser photocoagulation therapy. HbA1c was measured at the end of study.
Results
Significance level was set at P<0.05. A significant difference in the foveal (P=0.02) and superior (P=0.021) retinal thickness 6 months after laser therapy, no correlation between HbA1c and retinal thickness after photocoagulation, and an insignificant decrease in visual acuity (P=0.9) were found. The correlation between foveal retinal thickness and visual acuity was P=0.24 6 months after treatment.
Conclusion
There was no significant correlation between HbA1c and the effect of grid laser photocoagulation therapy in diffuse diabetic macular edema. The retinal thickness decreased significantly in the foveal and superior area 6 months after therapy. No correlation between the foveal retinal thickness and the visual acuity was found. The visual acuity did not increase after treatment. There are many factors influencing the retinal thickness, such as the blood pressure and the attached posterior hyaloid.
Similar content being viewed by others
References
Baumann M, Gentile RC, Liebmann JM, Ritch R (1998) Reproducibility of retinal thickness measurements in normal eyes using optical coherence tomography. Ophthalmic Surg Lasers 29:280–285
Besenthal I (2000) Glukosestoffwechsel. In: Neumeister B, Besenthal I, Liebich H (eds) Klinikleitfaden Labordiagnostik. Urban und Fischer Verlag, München Jena, pp 126–127
Brancato R (1999) Optical coherence tomography in macular edema. Doc Ophthalmol 97:337–339
Bresnick GH (1983) Diabetic maculopathy. A critical review highlighting diffuse macular edema. Ophthalmology 90:1301–1317
Capone A Jr, Panozzo G (2000) Vitrectomy for refractory diabetic macular edema. Semin Ophthalmol 15:78–80
Chantelau E (2001) What may be gained from standard photocoagulation during early worsening of diabetic retinopathy? An observational study in type-1 diabetic patients after tightening of glycemic control. Diabetes Metab 27:366–371
Chauhan DS, Marshall J (1999) The interpretation of optical coherence tomography images of the retina. Invest Ophthalmol Vis Sci 40:2332–2342
Early Treatment Diabetic Retinopathy Study Research Group (1991) ETDRS report number 7: Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. Ophthalmology 98:741–756
Frank RN, Schulz L, Abe K, Iezzi R (2004) Temporal variation in diabetic macular edema measured by optical coherence tomography. Ophthalmology 111:211–217
Goebel W, Kretzchmar-Gross T (2002) Retinal thickness in diabetic retinopathy: a study using optical coherence tomography (OCT). Retina 22:759–767
Hee MR, Izatt JA, Swanson EA, Huang D, Schuman JS, Lin CP, Puliafito CA, Fujimoto JG (1995) Optical coherence tomography of the human retina. Arch Ophthalmol 113:325–332
Hee MR, Puliafito CA, Duker JS, Reichel E, Coker JG, Wilkins JR, Schuman JS, Swanson EA, Fujimoto JG (1998) Topography of diabetic macular edema with optical coherence tomography. Ophthalmology 105:360–370
Hee MR, Puliafito CA, Wong C, Duker JS, Reichel E, Rutledge B, Schuman JS, Swanson EA, Fujimoto JG (1995) Quantitative assessment of macular edema with optical coherence tomography. Arch Ophthalmol 113:1019–1029
Hikichi T, Fujio N, Akiba Y, Takahashi M, Yoshida A (1997) Association between the short-term natural history of diabetic macular edema and the vitreomacular relationship in type II diabetes mellitus. Ophthalmology 104:473–478
Izatt JA, Hee MR, Swanson EA, Lin CP, Huang D, Schuman JS, Puliafito CA, Fujimoto JG (1994) Micrometer-scale resolution imaging of the anterior eye in vivo with optical coherence tomography. Arch Ophthalmol 112:1548–1589
Kang SW, Park CY, Ham DI (2004) The correlation between fluorescein angiographic and optical coherence tomographic features in clinically significant diabetic macular edema. Am J Ophthalmol 137:313–322
Klein R, Klein BE, Moss SE (1984) Visual impairement in diabetes. Ophthalmology 91:1–19
Klein R, Klein BE, Moss SE, Davis MD, DeMets DL (1984) The Wisconsin Epidemiologic Study of Diabetic Retinopathy, IV: diabetic macular edema. Ophthalmology 91:1464–1474
Klein R, Moss SE, Klein BE, Davis MD, DeMets DL (1989) The Wisconsin epidemiologic study of diabetic retinopathy. XI. The incidence of macular edema. Ophthalmology 96:1501–1510
Kojima T, Terasaki H, Nomura H, Suzuki T, Mori M, Ito Y, Miyake Y (2003) Vitrectomy for diabetic macular edema: effect of glycemic control (HbA(1c)), renal function (creatinine) and other local factors. Ophthalmic Res 35:192–198
Kremser BG, Kunze C, Troger J, Ulmer H, Kieselbach GK (1996) Grid pattern photocoagulation for diabetic macular edema–long term visual results. Ophthalmologica 210:160–162
Lattanzio R, Brancato R, Pierro L, Bandello F, Iaccher B, Fiore T, Maestranzi G (2002) Macular thickness measured by optical coherence tomography (OCT) in diabetic patients. Eur J Ophthalmol 12:482–487
Lee CM, Olk RJ (1991) Modified grid laser photocoagulation for diffuse diabetic macular edema: long-term visual results. Ophthalmology 98:1594–1602
Lopes de Faria JM, Jalkh AE, Trempe CL, McMeel JW (1999) Diabetic macular edema: risk factors and concomitants. Acta Ophthalmol Scand 77:170–175
Martidis A, Duker JS, Greenberg PB, Rogers AH, Puliafito CA, Reichel E, Baumal C (2002) Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 109:920–927
Massin P, Viscaut E, Haouchine B, Erginay A, Paques M, Gaudric A (2001) Reproducibility of retinal mapping using optical coherence tomography. Arch Ophthalmol 119:1135–1142
McDonald HR, Schatz H (1985) Macular edema following panretinal photocoagulation. Retina 5:5–10
Moreira RO, Trujillo FR, Meirelles RM, Ellinger VC, Zagury L (2001) Use of optical coherence tomography (OCT) and indirect ophthalmoscopy in the diagnosis of macular edema in diabetic patients. Int Ophthalmol 24:331–336
Nasrallah FP, Jalkh AE, Van Coppenrolle F, Kado M, Trempe CL, McMeel JW, Schepens CL (1988) The role of the vitreous in diabetic macular edema. Ophthalmology 95:1335–1339
Nasrallah FP, Van de Velde F, Jalkh AE, Trempe CL, McMeel JW, Schepens CL (1989) Importance of the vitreous in young diabetics with macular edema. Ophthalmology 96:1511–1517
Olk RJ (1986) Modified grid blue-green laser photocoagulation for diffuse diabetic macular edema. Ophthalmology 93:938–950
Olk RJ (1990) Argon green (514 nm) versus krypton red (647 nm) modified grid laser photocoagulation for diffuse diabetic macular edema. Ophthalmology 97:1101–1112
Otani T, Kishi S, Maruyama Y (1999) Patterns of diabetic macular edema with optical coherence tomography. Am J Ophthalmol 127:688–693
Perkovich BT, Meyers SM (1988) Systemic factors affecting diabetic macular edema. Am J Ophthalmol 105:211–212
Pieroth L, Schuman JS, Hertzmark E, Hee MR, Wilkins JR, Coker J, Mattox C, Pedut-Kloizman R, Puliafito CA, Fujimoto JG, Swanson E (1999) Evaluation of focal defects of the nerve fiber layer using optical coherence tomography. Ophthalmology 106:570–579
Puliafito CA, Hee MR, Lin CP, Reichel E, Schuman JS, Duker JS, Izatt JA, Swanson EA, Fujimoto JG (1995) Imaging of macular disease with optical coherence tomography. Ophthalmology 102:217–229
Sanchez-Tocino H, Alvarez-Vidal A, Maldonado MJ, Moreno-Montanes J, Garcia-Layana A (2002) Retinal thickness study with optical coherence tomography in patients with diabetes. Invest Ophthalmol Vis Sci 43:1588–1594
Schaudig UH, Glaefke C, Scholz F, Richard G (2000) Optical coherence tomography for retinal thickness measurement in diabetic patients without clinically significant macular edema. Ophthalmic Surg Lasers 31:182–186
Sebag J, Balazs EA (1984) Pathogenesis of CME: anatomic consideration of vitreoretinal adhesions. Surv Ophthalmol 29(suppl):493–498
Sebag J, Buckingham B, Charles MA, Reiser K (1992) Biochemical abnormalities of vitreous in humans with proliferative diabetic retinopathy. Arch Ophthalmol 110:1472–1476
Sebag J, Nie S, Reiser K, Charles MA, Yu NT (1994) Raman spectroscopy of human vitreous in proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 35:2976–2980
Stefaniotou M, Kalogeropoulos C, Psilas K (1995) Long-term visual results after laser photocoagulation for diabetic maculopathy. Ophthalmologica 209:64–67
Stolba U, Binder S, Gruber D, Krebs I, Aggermann T, Neumaier-Ammerer B (2005) Vitrectomy for persistent diffuse diabetic macular edema. Am J Ophthalmol 140:295–301
Toth CA, Narayan DG, Boppart SA, Hee MR, Fujimoto JG, Birngruber R, Cain CP, DiCarlo CD, Roach WP (1997) A comparison of retinal morphology viewed by optical coherence tomography and by light microscopy. Arch Ophthalmol 115:1425–1428
Varano M, Scassa C, Ripandelli G, Capaldo N (1999) New diagnostic tools for macular edema. Doc Ophthalmol 97:373–379
Yamamoto S, Yamamoto T, Hayahi M, Takeuchi S (2001) Morphological and functional analyses of diabetic macular edema by optical coherence tomography and multifocal electroretinograms. Graefe's Arch Ophthalmol 239:96–101
Yang CS, Cheng CY, Lee CF, Hsu WM, Liu JH (2001) Quantitative assessment of retinal thickness in diabetic patients with and without clinically significant macular edema using optical coherence tomography. Acta Ophthalmol Scand 79:266–270
Yanoff M, Fine BS (1996) Diabetes mellitus. In: Yanoff M, Fine BS (eds) Ocular pathology. Mosby-Wolfe, London, pp 563–565
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schmid, K.E., Neumaier-Ammerer, B., Stolba, U. et al. Effect of grid laser photocoagulation in diffuse diabetic macular edema in correlation to glycosylated haemoglobin (HbA1c). Graefe's Arch Clin Exp Ophthalmo 244, 1446–1452 (2006). https://doi.org/10.1007/s00417-006-0322-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-006-0322-6